FRANKLIN LAKES, N.J. & ASHLAND, Ore.–(BUSINESS WIRE)–FlowJo, LLC, the provider of the market-leading third-party software for single cell analysis, and BD Life Sciences – Biosciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that they have established a strategic relationship to integrate BD’s flow cytometry data acquisition […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today introduced Helios™, a CyTOF® platform that enables system-level biology at single-cell resolution, on an accessible, expandable system designed for breakthrough discovery. Mass cytometry has catalyzed the revolution of single-cell proteomics, enabling the most comprehensive understanding of cell phenotypes, signaling pathways and function. Helios dawns as the […]
The National Heart, Lung, and Blood Institute (NHLBI)-funded Next Gen Consortium has designated WiCell as the distributor of the human pluripotent stem cell lines created as part of the NHLBI’s Next Generation Genetic Association Studies. The Next Generation Genetic Association Studies (Next Gen) program is a five-year, $80 million program to investigate functional genetic variation […]
STOCKHOLM – ISSCR 2015–A new pluripotent stem cell (PSC) medium is designed to offer researchers unprecedented schedule flexibility, allowing two-day breaks from culture feeding without having to make changes to current workflows or compromise culture quality. Researchers can save time and reduce sample handling, thereby decreasing the risk of contamination. The Gibco Essential 8 Flex […]
The new technologies enable the advancement of nucleic acid research methods and open up new areas of biological enquiry for the Institute and wider science community. Providing researchers with access to better genome assemblies (commonly limited by poor input DNA), and through low input and single-cell transcriptomics, to an unprecedented understanding of the biochemical changes […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced its CallistoTM system, a fully automated and programmable microfluidic cell culture system that integrates multifactorial dosing in 32 individual chambers for simultaneous cell culture. This innovative new platform will revolutionize the way cell biologists develop in vitro cell models. By providing multifactorial dosing, transfection, and […]
GLASGOW, SCOTLAND – SOLVO Biotechnology and Hepregen Corporation announced today, at the 13th European Meeting of the International Society for the Study of Xenobiotics (“ISSX”), a co-marketing agreement between the companies. This agreement provides for the European marketing of Hepregen’s human, monkey, rat and dog application-directed HepatoPac® and HepatoMune™ kits, which are used for liver […]
Santa Clara, California — Crown Bioscience, Inc., a leading global drug discovery and preclinical development service company announced that is has added cell lines for biological studies and oncology drug screening to their Life Science division’s catalog. Three new categories of cell lines are available for purchase: EML4-ALK Kinase-Live cell lines are Crown’s stable Ba/F3 […]
YOKOHAMA, Japan – ReproCELL (JASDAQ:4978) is pleased to announce that we will start selling new culture medium for high quality human iPS (naïve type) for the first time in the world, “ReproNaïveTM”, into which the most advanced iPS cell technology is introduced. Since Professor Shinya Yamanaka of Kyoto University pioneered iPS technology in 2006, iPS […]
Albuquerque, New Mexico and Basel, Switzerland – Genedata and IntelliCyt today announced an alliance that brings together the market-leading strengths of each company to transform screening of suspension cells. The technology alliance integrates the highly-scalable data analytics and workflow capabilities of Genedata Screener® software with the high-throughput (HT) flow cytometry capabilities of the IntelliCyt iQue® […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
